SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: 2013 Report on the International Vaccine Market - Global Forecasts To 2022

[January 03, 2014]

Research and Markets: 2013 Report on the International Vaccine Market - Global Forecasts To 2022

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/xkfs22/vaccine_market_by) has announced the addition of the "2013 Report on the International Vaccine Market - Global Forecasts To 2022" report to their offering.

In general, the vaccine technology market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies.

This report analyzes the vaccine technology market both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available producs. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate.


The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided. An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed.

As well as technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Technology Snapshot (Page No. - 31)

4 Vaccine Research Portfolio

5 Value Chain Analysis

6 Market Landscape

7 Technology Adoption

8 Investment Analysis

9 Competitive Landscape

10 Regulatory Landscape

11 Patent Analysis

12 Analyst Recommendations

13 Company Profiles

Companies Mentioned:

  • Aduro Biotech
  • Alphavax
  • Antigen Express, INC
  • Bavarian Nordic
  • Biondvax Pharmaceuticals LTD
  • Genticel
  • Glaxo Smithkline PLC
  • Immune Targeting Systems (ITS)
  • Immunobiology LTD
  • Liquidia Technologies
  • Merck & CO, INC
  • Novartis AG
  • Pfizer, INC
  • Prokarium
  • Sanofi

For more information visit http://www.researchandmarkets.com/research/xkfs22/vaccine_market_by


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy